IP Library Granted Patent US 9,867,804
Granted Patent B2
US 9,867,804 · App. 15/195,011 · Granted Jan 16, 2018

Sodium ascorbate stimulation of elastogenesis

Inventors: Thomas F. Mitts (Visalia, CA); Aleksander Hinek (Toronto, CA); Hyunjun Jonathan Kim (Toronto, CA)
Assignees: Human Matrix Sciences, LLC; The Hospital for Sick Children
A61K31/375A61K8/42A61K8/676A61K31/221A61K45/06A61Q19/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,867,804
App. No.
15/195,011
Granted
Jan 16, 2018
Kind
B2
Abstract

Embodiments provide methods for using ascorbate for the stimulation of production of elastic fibers by cells.

Claims (7)

1. A composition comprising an effective amount of an ascorbate salt and an inhibitor of collagen deposition, wherein the ascorbate salt is selected from the group consisting of lithium ascorbate, sodium ascorbate, potassium ascorbate, magnesium ascorbate, calcium ascorbate, and combinations thereof, and

wherein the inhibitor of collagen deposition is selected from the group consisting of a spironolactone, eplerenone, dimethyloxaloylglycine, and a combination thereof.

2. The composition of claim 1 , wherein the ascorbate salt is delivered at a concentration of 50-200 micromolar to a tissue per dose.

3. The composition of claim 1 , wherein the inhibitor of collagen deposition is dimethyloxaloylglycine (DMOG).

4. The composition of claim 1 , wherein the composition is formulated to be administered by a mode selected from the group consisting of topical, parenteral, subcutaneous, intravenous, intraperitoneal, transdermal, oral, buccal, inhalation, depot injection, and implantation.

5. The composition of claim 1 , further comprising a diluent, a filler, a disintegrant, a binder, a lubricant, a surfactant, an emulsifier, a buffer, a humectant, a moisturizer, a solubilizer, a preservative, or a combination thereof.

6. The composition of claim 1 , wherein the composition is a solution, a powder, a fluid emulsion, a fluid suspension, an ointment, a paste, a cream, a gel, or a foam.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2024
From: ELASTOGENESIS LLC
To: NULASTIN, INC.
Reel/Frame 068190/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2024
From: THE HOSPITAL FOR SICK CHILDREN
To: ELASTOGENESIS LLC
Reel/Frame 067829/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2019
From: HUMAN MATRIX SCIENCES, LLC
To: ELASTOGENESIS, LLC
Reel/Frame 048891/0950 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2016
From: MITTS, THOMAS F.
To: HUMAN MATRIX SCIENCES, LLC
Reel/Frame 039030/0407 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2016
From: HINEK, ALEKSANDER
To: THE HOSPITAL FOR SICK CHILDREN
Reel/Frame 039030/0653 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2016
From: KIM, HYUNJUN JONATHAN
To: THE HOSPITAL FOR SICK CHILDREN
Reel/Frame 039030/0804 →
Continuity (3)
Continuation 13745393 · Jan 18, 2013
Provisional Application 61587864 · Jan 18, 2012
Related Publication 20160303071A1 · Oct 20, 2016